Linus Bosaeus has a diverse work experience in various industries. Linus is currently a Board Member at C-mo Medical Solutions, a digital health company specializing in cough monitoring for respiratory diseases. Prior to that, they served as the Chief Executive Officer at Rarity Bioscience. Linus also worked at NuvoAir, where they held roles as VP of Operations for Clinical Trials and Director of Operations. Linus was responsible for managing the development and growth of the Clinical Trial division, leading to a significant increase in sales. Linus also served as a Board Member at Muntra AB and held leadership positions at Endovascular Development AB. Linus has experience in business development, fundraising, sales, and customer engagement. Additionally, Linus has worked as a Research Engineer at FOI, Analyst at Swedish Defence Intelligence, Sales Representative & Account Manager at Eurostep AB, and conducted a Master Thesis on Risk Management at Volvo Trucks.
Linus Bosaeus completed their Master's degree in Engineering Physics from Uppsala University from 2002 to 2007. In 2006 to 2007, they attended the University of Colorado Boulder and studied Project Management, Product Development, Management & Leadership.
This person is not in any teams
This person is not in any offices
Rarity Bioscience
Rarity Bioscience provides ultrasensitive multiplex assays for mutation detecting in blood and other liquid biopsies for research, pharma and clinics. The sensitivity of our precision diagnostics technology enables patient stratification, treatment choice & monitoring, early MRD and relapse detection and post-transplantation follow-up for optimized cancer care. It also enables refined inclusion stratification and monitoring in clinical trials. The company was founded 2021 based on a discovery by Dr Lei Chen, PhD in molecular biology and a member of Professor Ulf Landegrens team at the Department of Immunology, Genomics and Pathology at Uppsala University.